IN8bio, Inc. announced the issuance of an additional European patent covering the composition of matter for IN8bio’s Drug Resistant Immunotherapy platform.
[IN8bio, Inc.]
Home Newsletters Immune Regulation News Newly Issued European Patent Broadens IN8bio’s Drug Resistant Immunotherapy (DRI) Platform
